Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
December 31, 2024 0.179M
September 30, 2024 0.172M
June 30, 2024 0.189M
March 31, 2024 0.209M
December 31, 2023 0.285M
September 30, 2023 0.275M
June 30, 2023 0.286M
March 31, 2023 0.298M
December 31, 2022 0.323M
September 30, 2022 0.328M
June 30, 2022 0.357M
March 31, 2022 0.318M
December 31, 2021 0.313M
September 30, 2021 0.244M
June 30, 2021 0.293M
March 31, 2021 0.28M
December 31, 2020 0.299M
September 30, 2020 0.305M
June 30, 2020 0.345M
March 31, 2020 0.331M
December 31, 2019 0.354M
September 30, 2019 0.393M
June 30, 2019 0.40M
March 31, 2019 0.42M
December 31, 2018 0.462M
Date Value
September 30, 2018 0.372M
June 30, 2018 0.358M
March 31, 2018 0.359M
December 31, 2017 0.352M
September 30, 2017 0.353M
June 30, 2017 0.321M
March 31, 2017 0.33M
December 31, 2016 0.356M
September 30, 2016 0.348M
June 30, 2016 0.3502M
March 31, 2016 0.3605M
December 31, 2015 0.3471M
September 30, 2015 0.392M
June 30, 2015 0.4371M
March 31, 2015 0.4558M
December 31, 2014 0.3623M
September 30, 2014 0.3638M
June 30, 2014 0.2774M
March 31, 2014 0.345M
December 31, 2013 0.2671M
September 30, 2013 0.2033M
June 30, 2013 0.19M
March 31, 2013 0.1647M
December 31, 2012 0.1465M
September 30, 2012 0.2971M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. --
Labcorp Holdings, Inc. --
OPKO Health, Inc. 33.17M
NeoGenomics, Inc. 10.76M
First Choice Healthcare Solutions, Inc. --